SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing intense selling pressure following a quarterly report that revealed significant headwinds in China and ongoing concerns regarding the impact of tariffs on margins. Investors are actively debating the company's long-term relevance and the effectiveness of management's turnaround efforts, with many expressing frustration over the stock's persistent decline compared to its historical performance.

Tema ETF Trust - Tema Space Innovators ETF

The newly launched Tema Space Innovators ETF ($NASA) is generating intense debate, with traders speculating it could mimic the high-volatility price action of other niche space-sector funds. While some investors are optimistic about its strategic exposure to industry leaders like SpaceX, critics are raising concerns regarding its low assets under management and the transparency of its underlying private holdings.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending due to a wave of community sentiment surrounding its potential for long-term institutional adoption and recent shifts in foundation leadership. While bullish participants are actively discussing the ecosystem's utility and technical roadmap, the stock remains a subject of intense debate, with many traders closely monitoring its price action for signs of a meaningful recovery from recent lows.

Ganymede

Ganymede is gaining traction as community members highlight its clean technical structure and consistent accumulation patterns. Investors are actively discussing the potential for significant momentum, viewing the current price action as a disciplined buildup phase.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors weigh its potential as a key supplier for AI infrastructure against concerns over its timeline for production-level revenue and historical management communications. While the community actively debates whether the stock is in a long-term accumulation phase fueled by partnerships with industry players or being held back by a lack of crystallized orders, discussion is intensified by upcoming earnings expectations and ongoing speculation regarding its role in high-speed optical data transmission.

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. The firm's products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.

Utah Medical Products, Inc.

Utah Medical Products is currently under investor scrutiny as recent earnings reports reveal a decline in profitability and a squeeze on margins due to OEM weakness and international sales challenges. While some community members highlight the company's debt-free balance sheet and dividend history as signs of resilience, others express concern over customer concentration risks and ongoing legal liabilities.

Aave is a decentralized money market protocol where users can lend and borrow cryptocurrency across 20 different assets as collateral. The protocol has a native token called AAVE, which is also a governance token that lets the community decide the direction of the protocol in a collective manner. Lenders can&nbsp;earn interest by providing liquidity to the market, while borrowers can borrow by collateralizing their cryptoassets to take out loans from the liquidity pools.

AAVE

AAVE is trending as investors focus on its institutional-grade DeFi infrastructure, with recent activity bolstered by significant token acquisitions from World Liberty Financial and continued optimism around the upcoming Aave V4 architecture. Community sentiment remains largely bullish, centered on AAVE's fundamental value, revenue-generating capabilities, and its role as a key player in bridging decentralized and traditional finance.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is currently a major focus for investors as the market anticipates the release of initial commercial sales data for its newly launched drug, Yartemlea. While the community is actively debating the stock's valuation, they are closely monitoring upcoming catalyst events, including potential European regulatory milestones and milestone payments from the ongoing partnership with Novo Nordisk.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is experiencing significant upward momentum driven by surging demand for AI-focused data storage, with institutional investors initiating high-conviction bullish ratings. The stock is a focal point of community discussion as traders debate the sustainability of this rally compared to broader semiconductor peers and the structural expansion of the data storage cycle.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is currently seeing significant community interest driven by speculation surrounding major exchange listings and potential institutional partnerships. While some investors are actively accumulating based on the project's reported high transaction speeds and long-term utility goals, others are debating whether current price volatility reflects a legitimate consolidation or a pump-and-dump cycle.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BW Investors Have Opportunity to Join Babcock & Wilcox Enterprises, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Babcock & Wilcox Enterprises, Inc. (B&W or the Company) (NYSE...

Babcock (NYSE:BW) Short Interest Update

Babcock (NYSE:BW - Get Free Report) was the target of a significant increase in short interest in March. As of March 13th, there was short interest totaling 6,350,606 shares, an increase of 84.9...

Babcock (NYSE:BW) Shares Down 7.5% - Should You Sell?

Babcock (NYSE:BW) Stock Price Down 7.5% - Should You Sell...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Babcock & Wilcox Enterprises, Inc. - BW

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Babcock & Wilcox Enterprises, Inc. - BW INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors...

Babcock & Wilcow Enterprises (BW) Is Up 44.43% in One Week: What You Should Know 

Does Babcock & Wilcow Enterprises (BW) have what it takes to be a top stock pick for momentum investors? Let's find out.

Wall Street Analysts Think Babcock & Wilcox (BW) Could Surge 44.39%: Read This Before Placing a Bet

The mean of analysts' price targets for Babcock & Wilcox (BW) points to a 44.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Babcock (BW) to Release Quarterly Earnings on Monday

Babcock (NYSE:BW) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-babcock-wilcox-enterprises-inc-stock...

Babcock (NYSE:BW) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen raised Babcock from a "hold" rating to a "buy" rating in a research note on Saturday...

Insider Buying: Babcock (NYSE:BW) CFO Purchases 1,285 Shares of Stock

Babcock (NYSE:BW - Get Free Report) CFO Cameron Frymyer bought 1,285 shares of the firm's stock in a transaction that occurred on Wednesday, March 18th. The stock was acquired at an average cost of...

Northland Securities Raises Earnings Estimates for Babcock

Babcock (NYSE:BW - Free Report) - Equities research analysts at Northland Securities lifted their FY2026 earnings per share estimates for shares of Babcock in a report issued on Tuesday, March 17th. Northland Securities analyst J. Grampp now forecasts that the technology company will post earnings o...

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Sprott Silver Miners & Physical Silver ETF ($SLVR)

Tradr 2x Long Innovation 100 Monthly ($MQQQ)

GraniteShares Autocallable NVDA ETF ($ANV)

Direxion Daily ASML Bull 2x ($ASMU)

The ultimate tool for the active trader. This award goes to the fund that helped traders master the market—whether by protecting against risks or jumping on the latest trends to capture quick wins.

Current Price	$14.69
Prev Close	$13.21
Open	$13.81
Dividend Yield	0.00%
50-Day Moving Average	$11.18
Beta	2.49
Avg. Volume	2.34M
PE Ratio	-16.83

52-Week High	$16.24
52-Week Low	$0.2241
Market Capitalization	$1.79B
EPS (Annual)	-$0.8526
Price to Book	-14.56
Revenue Per Employee	$356,167.27

BW
Babcock & Wilcox Enterprises Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BW News

BWBabcock & Wilcox Enterprises Inc